دوره 5، شماره 1 - ( 10-1392 )
جلد 5 شماره 1 صفحات 48-46 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mobini M. Alendronate-Related Femoral Fracture in a premenopausal glucocorticoid treated patient . Caspian J Intern Med 2014; 5 (1) :46-48
URL: http://caspjim.com/article-1-43-fa.html
URL: http://caspjim.com/article-1-43-fa.html
Alendronate-Related Femoral Fracture in a premenopausal glucocorticoid treated patient . . 1392; 5 (1) :46-48
چکیده: (29809 مشاهده)
Abstract
Background: Alendronate is a bisphosphonate that is approved to reduce bone loss in glucocorticoid treated patients. In this paper, we present a case of femoral fracture following the use of Alendronate.
Case presentation: A- 46 year old woman who was a known case of hemolytic anemia has been treated by prednisolone (with different doses from 7.5 to 75 mg/day), calcium-D 500 mg/day and alendronate 70 mg/week for 3 years. Despite improvement of bone density, she experienced a low truama femoral shaft fracture.
Conclusion: This case shows a rare complication of treatment by alendronate. It may be needed to evaluate patients with long term usage of bisphosphonates for cortical thickness.
نوع مطالعه: Original Article |
موضوع مقاله:
Infectious Diseases
دریافت: 1392/9/30 | پذیرش: 1392/9/30 | انتشار: 1392/9/30
دریافت: 1392/9/30 | پذیرش: 1392/9/30 | انتشار: 1392/9/30
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |